Format

Send to

Choose Destination
Nephron Clin Pract. 2014;127(1-4):139-43. doi: 10.1159/000363209. Epub 2014 Sep 24.

Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease.

Author information

1
Department of Medicine, Johns Hopkins University, Baltimore, Md., USA.

Abstract

The pathophysiology of acute kidney injury (AKI) involves multiple and overlapping immunological, biochemical, and hemodynamic mechanisms that modulate the effects of both the initial insult and the subsequent repair. Limited but recent experimental data have revealed that the intestinal microbiota significantly affects outcomes in AKI. Additional evidence shows significant changes in the intestinal microbiota in chronic kidney disease patients and in experimental AKI. In this minireview, we discuss the current status of the effect of intestinal microbiota on kidney diseases, the immunomodulatory effects of intestinal microbiota, and the potential mechanisms by which microbiota can modify kidney diseases and vice versa. We also propose future studies to clarify the role of intestinal microbiota in kidney diseases and to explore how the modification of gut microbiota may be a potential therapeutic tool.

PMID:
25343838
PMCID:
PMC4985236
DOI:
10.1159/000363209
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center